AlyveRx review

AlyveRx has one feature a low-dose reader should care about: it sells injection-free sublingual drops for both molecules, each with its own published rate, rather than treating the needle-free route as a special request. That is a real option for someone taking a small amount who does not want to inject weekly. It also lets you route the prescription to a pharmacy of your own choosing instead of forcing its network, which is unusual. Against that sits a pricing page that contradicts itself. The same compounded tirzepatide appears at two different figures on the same page, and both are floors — every GLP-1 rate here is a "starting at" with no higher rung published anywhere. When a provider cannot state its own entry price consistently, treat every figure on the page as provisional and get a quote in writing before you commit.

Vs median

$8/mo above the $175 median across the 299 of 548 programs here that publish a plain monthly rate

Market

$59–$1,300/mo is the full published spread on this site

Structure

Quotes off the lowest dose

Consult

Included in the price

Dietitian

Not confirmed

Labs

Not required

Pricing

Check plan terms

AlyveRx does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

AlyveRx sells compounded semaglutide and tirzepatide in both injectable and injection-free sublingual-drop forms, alongside compounded NAD+ and brand Ozempic, framing the catalog around weight loss and healthy aging. Splitting each molecule into an injectable and a drop, each separately priced, is genuinely useful to someone who wants to avoid needles at a low dose. The pricing itself is where it falls down: the same compounded tirzepatide carries two different published figures on one page load, and every GLP-1 rate is a "starting at" with no second rung published against it. Its terms describe fulfillment through an unnamed network of licensed pharmacies and compounding facilities, though a patient may request a pharmacy of their own choosing.

TWO PRICES FOR ONE PRODUCT. Compounded tirzepatide is published at $329/month in one place on the homepage and "Starting at $283/mo" in another, in the same render — reproduced on a second fetch, so it is not a caching artifact

• Every GLP-1 figure is a "starting at" floor with no higher-dose rung published, so a dose increase has an unknown price
• No pharmacy is named — its terms describe only "licensed pharmacies or compounding facilities within our network"
• No LegitScript seal is displayed
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

AlyveRx is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• Sublingual troches and drops
• The true annual cost of a plan